Crystal's MCW Coder Hub🧬 ICD-10-CM H35.70 — Unspecified Separation of Retinal Layers
Quick Reference
Code: H35.70 | Billable: Yes | Chapter: 7 — Eye and Adnexa | HCC: No (H35.70 itself) | Laterality: None — no laterality character; unspecified type and eye ⚠️ CDI Priority Code — separation type AND eye laterality are both unspecified; two independent CDI query opportunities exist at every encounter where this code appears
Description
ICD-10 CM H35.70 identifies an unspecified separation of retinal layers — a broad category covering any documented disruption of normal retinal layer apposition where the provider has not specified which type of separation is present or which eye is affected. The H35.7 subcategory encompasses three anatomically and clinically distinct entities: central serous chorioretinopathy (CSC) (H35.71x), serous detachment of the retinal pigment epithelium (RPE) (H35.72x), and hemorrhagic detachment of the RPE (H35.73x) — all representing separations occurring at or beneath the level of the RPE, fundamentally distinct from the neurosensory retinal detachments classified under H33.12
ICD-10 CM H35.70 is the least specific code in the H35.7 family — it carries no laterality, no type specification, and no subtype detail. As a profee coder working retina and vitreoretinal charts, H35.70 should function as an immediate CDI red flag: the type of retinal layer separation (CSC vs. serous PED vs. hemorrhagic PED) is virtually always determinable from OCT findings, fluorescein angiography, or ICGA documented in the clinical record, and the affected eye is almost always specified in the provider’s assessment. Defaulting to H35.70 when the clinical documentation supports H35.711, H35.721, H35.731, or any of their more specific siblings represents both a coding accuracy failure and a missed opportunity to accurately capture the clinical picture — including any associated AMD codes that carry HCC 124 weight.3
H35.7 (Separation of Retinal Layers) vs. H33 ( Retinal Detachment) — Critical Anatomical Distinction
Feature Separation of Retinal Layers (H35.7x) Retinal Detachment (H33.x) Anatomical plane Separation at or beneath the RPE (CSC, serous PED, hemorrhagic PED) OR between RPE and neurosensory retina (CSC subretinal fluid) Separation of full neurosensory retina from the RPE — macro-level detachment Mechanism Choroidal hyperpermeability (CSC), fluid accumulation beneath RPE (serous PED), hemorrhage beneath RPE (hemorrhagic PED) Rhegmatogenous (break + fluid), serous (transudation), or tractional (membrane) Visual threat Subacute — CSC may resolve spontaneously; RPE detachments threaten RPE pump function and overlying photoreceptors Acute/subacute — macula-off RD is a surgical emergency OCT key finding Subretinal fluid beneath neurosensory retina (CSC); dome-shaped RPE elevation with optically clear (serous) or dense (hemorrhagic) contents Neurosensory retinal elevation with subretinal fluid; photoreceptors separated from RPE ICD-10-CM H35.7x ← THIS family H33.0x (rhegmatogenous), H33.2x (serous RD), H33.4x (tractional) Excludes1 H35.7x Excludes1 H33.2x (serous RD) and H33.0x (rhegmatogenous RD) — mutually exclusive Classified under H33; distinct from H35.7 The most clinically important separation to master is CSC (H35.71x) vs. serous retinal detachment (H33.2x) — in CSC, the fluid originates from RPE dysfunction and choroidal hyperpermeability, whereas in serous RD, the neurosensory retina lifts as a whole. Both may show subretinal fluid on OCT, but the anatomical origin, extent, and management differ profoundly. These are Excludes1 — mutually exclusive at the encounter level for the same eye.1
Code Structure & Hierarchy
Code Tree
- Chapter: 7 — Diseases of the Eye and Adnexa (H00-H59)
- Block: H30-H36 — Disorders of Choroid and Retina
- H35 — Other retinal disorders ← this category
- H35.7 — Separation of retinal layers ← this subcategory
- H35.70 — Unspecified separation of retinal layers ← this code ✅ (No laterality character — unspecified type AND unspecified eye)
- H35.71 — Central serous chorioretinopathy (CSC)
- H35.72 — Serous detachment of retinal pigment epithelium
- H35.73 — Hemorrhagic detachment of retinal pigment epithelium
Unique Structure of H35.70
ICD-10 CM H35.70 is structurally unusual within the H35.7 family — it is a 5-character code with no laterality extension, while all of its sibling subcategories (H35.71, H35.72, H35.73) use a 6-character structure to specify laterality (1 = right, 2 = left, 3 = bilateral, 9 = unspecified eye). H35.70 functions as the “type unspecified” code for the entire H35.7 subcategory and does not carry the additional laterality character found in its siblings.
H35.70 vs. Sibling Codes — Type Specificity Decision Table
Code Type Assign When Provider Documents… H35.70 Unspecified ”Separation of retinal layers NOS” — no type described anywhere in the complete record H35.71x Central Serous Chorioretinopathy (CSC) “CSC,” “central serous retinopathy,” “serous subretinal fluid,” “idiopathic central serous chorioretinopathy” — subretinal fluid beneath neurosensory retina over the macula from RPE dysfunction2 H35.72x Serous detachment of RPE ”Serous PED,” “serous RPE detachment,” “pigment epithelial detachment, serous,” “dome-shaped RPE elevation, optically clear on OCT” — fluid beneath the RPE lifting it from Bruch’s membrane16 H35.73x Hemorrhagic detachment of RPE ”Hemorrhagic PED,” “blood under the RPE,” “hemorrhagic pigment epithelial detachment,” “dense RPE elevation on OCT” — hemorrhage between the RPE and Bruch’s membrane16 In practice, OCT is the diagnostic cornerstone for distinguishing among these three entities — the contents beneath the RPE (optically clear = serous; dense/hyperreflective = hemorrhagic) and the plane of fluid (beneath neurosensory retina vs. beneath RPE) determine which code family applies. If OCT has been performed and documented, H35.70 should never appear on a finalized claim.
Instructional Notes
Excludes1 at H35.7 Subcategory Level — Mutually Exclusive
Cannot be coded together with H35.70 or any H35.7x code at the same encounter for the same eye:
- Retinal detachment, serous (H33.2-) — serous RD involves lifting of the full neurosensory retina from the RPE by serous fluid (exudative/non-rhegmatogenous mechanism); this is anatomically and clinically distinct from RPE-level separation and CSC; these codes are Excludes1 — mutually exclusive17
- Rhegmatogenous retinal detachment (H33.0-) — full-thickness break with subretinal fluid; fundamentally distinct from separation at the RPE level; Excludes1 — mutually exclusive1
Excludes2 at H35 Category Level — May Coexist, Separately Reportable
The following must be coded separately when documented in addition to H35.70 or its siblings:
- Diabetic retinal disorders (E08.311-E13.359) — diabetic retinopathy codes are Excludes2 at the H35 category level; when separation of retinal layers occurs in a diabetic patient, both the H35.7x code AND the appropriate diabetic retinopathy code must be assigned; the diabetic code is NOT assumed to subsume the H35.7x finding13
- Exudative AMD (H35.3211-H35.3222) — serous and hemorrhagic RPE detachments very commonly occur as manifestations of wet AMD; the AMD code and the RPE detachment code are both reportable and both clinically essential — the AMD code carries HCC 124 weight under CMS-HCC v28 and must be captured9
- Posterior vitreous detachment (H43.81-) — may coexist; separately reportable when documented
Use Additional Code
- H35.32- — Exudative age-related macular degeneration; code additionally when serous or hemorrhagic RPE detachment is a manifestation of wet AMD — this is one of the most important additional code pairings in all of macular coding; the AMD code carries HCC 124 weight9
- H43.81- — Posterior vitreous detachment; separately reportable when documented as a coexisting finding
- Appropriate E-code for diabetic etiology when documented — mandatory per Excludes2 instruction; carries HCC 122 (diabetes with retinopathy) weight3
Clinical Description
The H35.7 family covers three distinct but related entities involving separation at the level of the retinal pigment epithelium (RPE) or between the RPE and the overlying neurosensory retina. All three represent disruptions of the normal anatomical apposition between the RPE, Bruch’s membrane, and the photoreceptor layer — occurring at a fundamentally different anatomical plane than the full retinal detachments classified under H33.
1. Central Serous Chorioretinopathy (CSC) — H35.71x
CSC is an idiopathic maculopathy characterized by accumulation of serous fluid beneath the neurosensory retina in the macular region, driven by choroidal vascular hyperpermeability and localized RPE dysfunction.213 It is primarily a disease of young to middle-aged males (age 20-50) with a strong association with stress, corticosteroid use (exogenous or endogenous — Cushing’s), type A personality, and elevated cortisol levels.
- Pathophysiology: Choroidal congestion and hyperpermeability → focal breakdown of the outer blood-retinal barrier at the RPE → serous fluid leaks through the RPE into the subretinal space → dome-shaped neurosensory retinal detachment over the macula2
- Acute CSC: Self-limiting in ~80-90% of cases within 3-4 months; observation is often the first-line approach; visual acuity typically recovers to near-normal14
- Chronic CSC (>3-4 months duration): Progressive RPE decompensation; persistent subretinal fluid; risk of permanent photoreceptor damage; treatment is warranted — half-dose PDT is the current evidence-based standard of care, demonstrating superior fluid resolution and visual outcomes over anti-VEGF and observation in a 2026 meta-analysis7
- OCT: Dome-shaped neurosensory retinal detachment; subretinal fluid optically clear; RPE may show small PEDs at leak point; choroidal thickening on EDI-OCT (“pachychoroid” phenotype) is characteristic2
- FA: Classic “smokestack” or “inkblot” pattern of leakage at the RPE focal defect
- ICGA: Choroidal hyperpermeability; dilated choroidal vessels; essential for identifying the site of treatment in chronic CSC14
2. Serous Detachment of Retinal Pigment Epithelium — H35.72x
Serous PED is a dome-shaped elevation of the RPE from Bruch’s membrane containing optically clear serous fluid — fluid accumulation in the sub-RPE space without blood.16 It is most commonly a manifestation of wet (exudative) AMD but can also occur in CSC, polypoidal choroidal vasculopathy (PCV), and idiopathically.
- Represents leakage from choroidal neovascularization (CNV) or choroidal hyperpermeability accumulating beneath the RPE
- OCT: Smooth dome-shaped RPE elevation; optically clear (dark) sub-RPE contents; sharp RPE reflectivity maintained; may coexist with subretinal fluid (neurosensory separation above the PED)
- AMD-associated serous PED: Code BOTH H35.721-H35.729 AND the appropriate exudative AMD code (H35.3211 etc.) — the AMD code is the underlying etiology and carries HCC 124 weight9
- CSC-associated serous PED: Code BOTH H35.71x (CSC, primary) AND H35.72x (serous PED, secondary) when both are documented — they coexist frequently in CSC and are separately reportable
3. Hemorrhagic Detachment of Retinal Pigment Epithelium — H35.73x
Hemorrhagic PED is a dome-shaped elevation of the RPE from Bruch’s membrane containing blood — hemorrhage in the sub-RPE space, producing a dense, dark, irregular elevation on OCT.16 It is most commonly associated with wet AMD with CNV, polypoidal choroidal vasculopathy (PCV), or trauma.
- OCT: Dense hyperreflective dome-shaped RPE elevation with posterior shadowing; sharp anterior RPE boundary but irregular posterior margin due to hemorrhagic contents
- FA: Hypofluorescent (“blocked fluorescence”) due to blood blocking underlying choroidal fluorescence
- Clinical urgency: Hemorrhagic PED with rapid expansion signals active CNV and is an indication for urgent anti-VEGF treatment — visual prognosis worsens with delay16
- AMD-associated hemorrhagic PED: Code BOTH H35.73x AND the appropriate exudative AMD code (H35.3221 etc.) — both are required; AMD carries HCC 124 weight
OCT Summary — Three Subtypes at a Glance:
| Feature | CSC (H35.71x) | Serous PED (H35.72x) | Hemorrhagic PED (H35.73x) |
|---|---|---|---|
| Plane of separation | Between RPE and photoreceptors (subretinal fluid) | Between RPE and Bruch’s membrane (sub-RPE fluid) | Between RPE and Bruch’s membrane (sub-RPE blood) |
| OCT contents | Optically clear subretinal fluid | Optically clear sub-RPE fluid (dark) | Hyperreflective dense material (blood) with shadowing |
| RPE shape | Flat or slightly elevated; focal PED at leak point | Smooth dome-shaped RPE elevation | Irregular dome-shaped RPE elevation |
| FA pattern | Smokestack or inkblot | Hyperfluorescent PED | Hypofluorescent (blocked by blood) |
| Primary association | Choroidal hyperpermeability, stress, steroids | Wet AMD, CSC, PCV | Wet AMD with CNV, PCV, trauma |
| HCC-relevant pairing | No direct HCC | AMD code (H35.32-) → HCC 124 | AMD code (H35.32-) → HCC 124 |
Coding Guidelines
Official Guideline Reference
ICD-10-CM Official Guidelines FY2026, Section I.C.7 — Diseases of the Eye and Adnexa
- Assign H35.70 only when the provider documents a separation of retinal layers and neither the specific type (CSC, serous PED, hemorrhagic PED) nor the affected eye can be determined from the complete medical record. In practice, this code should be extremely rare — OCT documentation almost always provides sufficient information to assign a more specific code.3
- Diabetic retinopathy (E08.311-E13.359) is Excludes2 at the H35 category level — always code the diabetic etiology separately when separation of retinal layers occurs in a diabetic patient; do not allow the H35.7x code to stand alone without the diabetes code when a diabetic etiology is documented.3
- When serous or hemorrhagic RPE detachment is documented as a manifestation of exudative AMD, code both the H35.7x code AND the appropriate exudative AMD code (H35.32-) — the AMD code is the underlying etiology and must be separately captured; it carries HCC 124 weight under CMS-HCC v28.9
- Serous RD (H33.2-) and H35.7x are Excludes1 at the subcategory level — they cannot be coded simultaneously for the same eye at the same encounter; the anatomical distinction (full neurosensory retinal detachment vs. RPE-level separation) must be documented by the provider before code assignment.1
Sequencing Tips
- Outpatient — First-listed diagnosis: H35.70 (or more specific H35.7x code) when separation of retinal layers is the primary reason for the encounter
- AMD-driven RPE detachment: Sequence the AMD code (H35.32-) as the first-listed diagnosis when AMD is the underlying condition driving the encounter — the RPE detachment (H35.72x or H35.73x) is coded as an additional manifestation
- CSC: H35.71x is typically the first-listed diagnosis — CSC is usually the primary reason for the encounter and does not have an underlying etiology code that would take precedence
- Diabetic etiology: The diabetic code (E11.35xx etc.) is sequenced according to the reason for the encounter; per ICD-10-CM convention, either the E-code or the manifestation code may be first-listed depending on the clinical context
- POA (inpatient): Almost always Y — separation of retinal layers is a chronic or subacute macular condition. POA = N is essentially never applicable.
- Bilateral CSC: Bilateral CSC is documented in approximately 20-30% of CSC patients — if both eyes are confirmed, H35.713 is required rather than separate unilateral codes
HCC Mapping
HCC Risk Adjustment
HCC Relevant: No — for H35.70 itself HCC Model: CMS-HCC v28 — fully operative CY2026 HCC Category: Not mapped (H35.70 directly) HCC Coefficient: 0.000 Risk Adjustment Impact: None — for H35.70 in isolation
H35.70 carries no HCC weight under CMS-HCC v28. However, this code almost always coexists with conditions that carry significant HCC weight — particularly exudative AMD (H35.32- → HCC 124) and diabetic retinopathy (E11.35xx → HCC 122). The failure to capture these associated codes when H35.70 is used as a standalone code represents a meaningful risk adjustment documentation gap.
⚠️ HCC Opportunities Associated with H35.7x — High Priority
Condition ICD-10-CM Code HCC Category (V28) Notes Exudative AMD with active CNV H35.3211 (right), H35.3221 (left) etc. HCC 124 Most common underlying cause of serous/hemorrhagic PED — must be coded separately; Excludes2 allows dual coding9 Type 2 DM with diabetic macular edema E11.3511-E11.3593 HCC 122 Diabetic RPE changes separately reportable; Excludes2 at H35 level3 Type 1 DM with retinopathy E10.3511-E10.3593 HCC 122 Same as above Degenerative myopia with CNV H44.2A1/H44.2A2/H44.2A3 Verify V28 mapping Myopic CNV can cause serous/hemorrhagic PED — separately reportable When H35.70 appears on a claim without any associated AMD or diabetic code, that is a CDI flag — serous and hemorrhagic PEDs almost never occur in isolation without an identifiable underlying condition in adult patients.
MS-DRG Mapping
DRG Assignment
MS-DRG Description MDC GMLOS 124 Other Disorders of the Eye with MCC MDC 2 4.6 125 Other Disorders of the Eye with CC MDC 2 3.1 126 Other Disorders of the Eye without CC/MCC MDC 2 2.2
CC/MCC Status & Inpatient Context
- CC status: No
- MCC status: No
- HAC designation: No
- POA exempt: No
- Inpatient note: Inpatient admission for separation of retinal layers alone is uncommon — intravitreal injections (67028), PDT (67221/67225), and laser photocoagulation (67210/67228) are all outpatient procedures. H35.70 and its siblings most commonly appear as secondary diagnoses in the inpatient setting — for example, CSC or serous PED noted during an admission for another primary condition. The associated AMD or diabetic retinopathy codes that frequently accompany H35.7x diagnoses are also non-CC/MCC at the H35/E11 level in most cases, though certain combinations with systemic comorbidities may interact with DRG assignment. The DRG is driven by the principal diagnosis and any qualifying CC/MCC secondary codes.
CPT Crosswalk
| CPT | Description | wRVU (approx.) | Global Period | Modifier |
|---|---|---|---|---|
| 92004 | Ophthalmological exam, new patient, comprehensive, with dilation | 2.67 | 0 days | N/A |
| 92014 | Ophthalmological exam, established patient, comprehensive, with dilation | 1.34 | 0 days | N/A |
| 92134 | OCT posterior segment (retina), with interpretation and report | 0.00 (TC/PC) | 0 days | RT / LT / 50 |
| 92137 | OCTA — optical coherence tomography angiography, posterior segment, with interpretation and report (NEW Category I CPT — effective January 1, 2025) | 0.00 (TC/PC) | 0 days | RT / LT / 50 |
| 92235 | Fluorescein angiography (FA) with interpretation and report | ~1.22 | 0 days | RT / LT / 50 |
| 92240 | Indocyanine green angiography (ICGA) with interpretation and report | ~1.22 | 0 days | RT / LT / 50 |
| 92242 | Fluorescein + ICG angiography together, with interpretation and report (NEW — effective 2025) | ~1.50 | 0 days | RT / LT / 50 |
| 92250 | Fundus photography with interpretation and report | 0.00 (TC/PC) | 0 days | N/A |
| 92225 | Ophthalmoscopy, extended, with retinal drawing, initial | ~1.75 | 0 days | RT / LT |
| 92226 | Ophthalmoscopy, extended, with retinal drawing, subsequent | ~1.50 | 0 days | RT / LT |
| 67028 | Intravitreal injection of pharmacologic agent (anti-VEGF, steroid, etc.) | ~1.30 | 0 days | RT / LT |
| 67210 | Destruction of localized lesion of retina; photocoagulation | ~3.75 | 90 days | RT / LT |
| 67228 | Treatment of extensive or progressive retinopathy; photocoagulation | ~5.00 | 90 days | RT / LT |
| 67221 | Destruction of localized lesion of choroid; photodynamic therapy (PDT), single session | ~5.10 | 90 days | RT / LT |
| 67225 | Destruction of localized lesion of choroid; photodynamic therapy (PDT), each additional session | ~3.80 | Included | RT / LT |
⚠️ New CPT Codes Effective 2025 — Critical Updates for Retinal Layer Separation Coding
Two new CPT codes that directly impact H35.7x coding workflows went into effect January 1, 2025:
92137 — OCTA (Optical Coherence Tomography Angiography):
- New Category I CPT code specifically for OCTA of the posterior segment — previously reported under 921348
- OCTA is particularly valuable for imaging the choriocapillaris in CSC, identifying CNV in serous and hemorrhagic PED, and mapping the pachychoroid phenotype
- Report 92137 for OCTA; report 92134 for standard structural OCT; both may be reportable on the same encounter if both studies are performed and documented
- Per AAO guidance, 92137 should NOT be reported with 92235, 92240, or 92242 — it is a standalone OCTA code8
92242 — Combined Fluorescein + ICG Angiography:
- New code for performing both FA and ICGA in the same session — replaces billing 92235 + 92240 together15
- Particularly relevant for CSC workup (FA identifies the RPE leak point; ICGA reveals choroidal hyperpermeability and pachychoroid vessels) and for wet AMD evaluation of PED
- Report 92242 when both FA and ICGA are performed at the same encounter rather than billing both 92235 and 92240 separately
67221 — PDT for CSC (Half-Dose Verteporfin)
Photodynamic therapy (67221) is the current evidence-based standard of care for chronic CSC (duration >3-4 months) and is increasingly used for acute CSC requiring rapid visual rehabilitation.7 Key billing considerations:
- 67221 covers a single session of PDT; 67225 covers each additional session — use 67225 for retreatment sessions in chronic CSC
- Half-dose (30%) or half-fluence verteporfin PDT is used for CSC to minimize choroidal damage — the CPT code is the same (67221) regardless of dose modification; document the dose modification in the operative note
- 90-day global period applies to 67221 — unlike 67141/67145 which changed to 10 days in 2022, PDT retains its 90-day global period
- A 2026 meta-analysis (PubMed 41833620) confirmed half-dose PDT is nearly 4x more likely to achieve complete fluid resolution at 1 month vs. observation in acute CSC, and provides durable anatomical and functional benefit through 12 months — superior to anti-VEGF in both acute and chronic CSC7
- Anti-VEGF (67028) may be used for CSC-associated CNV (MNV) — a secondary complication of chronic CSC; not first-line for uncomplicated CSC itself
NCCI Bundling
Per the CMS 2026 NCCI Medicare Coding Policy Manual:
- 92134 (structural OCT) and 92137 (OCTA) may be reported together when both studies are separately performed and documented at the same encounter — they are distinct diagnostic procedures
- 92235 and 92240 should NOT be reported together when 92242 (combined FA+ICGA) is available and performed — use 92242 for the combined study
- 67028 (intravitreal injection) may be reported on the same day as a diagnostic imaging service (92134, 92235, etc.) when both are performed and separately documented; review current NCCI edits for specific pairs
ICD-10-PCS Crosswalk
PCS Applicability
ICD-10-PCS applies in the inpatient setting only. Procedures for retinal layer separation (intravitreal injections, PDT, laser photocoagulation) are almost exclusively performed in the outpatient setting. ICD-10-PCS codes are not applicable to outpatient profee claims.
ICD-10-PCS is rarely applicable for H35.70
In the inpatient setting, H35.70 will almost always appear as a secondary diagnosis without a corresponding inpatient procedure performed for the retinal layer separation itself. PCS crosswalk is provided for completeness only in the event of an inpatient PDT or laser photocoagulation procedure.
ICD-10-CM Crosswalk
| Code | Description | Relationship |
|---|---|---|
| H35.711 | Central serous chorioretinopathy, right eye | Type + laterality upgrade — CSC, right |
| H35.712 | Central serous chorioretinopathy, left eye | Type + laterality upgrade — CSC, left |
| H35.713 | Central serous chorioretinopathy, bilateral | Type + laterality upgrade — CSC, bilateral |
| H35.719 | Central serous chorioretinopathy, unspecified eye | Type upgrade — CSC, eye unspecified |
| H35.721 | Serous detachment of RPE, right eye | Type + laterality upgrade — serous PED, right |
| H35.722 | Serous detachment of RPE, left eye | Type + laterality upgrade — serous PED, left |
| H35.723 | Serous detachment of RPE, bilateral | Type + laterality upgrade — serous PED, bilateral |
| H35.729 | Serous detachment of RPE, unspecified eye | Type upgrade — serous PED, eye unspecified |
| H35.731 | Hemorrhagic detachment of RPE, right eye | Type + laterality upgrade — hemorrhagic PED, right |
| H35.732 | Hemorrhagic detachment of RPE, left eye | Type + laterality upgrade — hemorrhagic PED, left |
| H35.733 | Hemorrhagic detachment of RPE, bilateral | Type + laterality upgrade — hemorrhagic PED, bilateral |
| H35.739 | Hemorrhagic detachment of RPE, unspecified eye | Type upgrade — hemorrhagic PED, eye unspecified |
| H35.3211 | Exudative AMD, right eye, with active CNV | Most common underlying cause of serous/hemorrhagic PED — HCC 124; code separately |
| H35.3221 | Exudative AMD, left eye, with active CNV | Same — code separately; HCC 124 |
| H33.21 | Serous retinal detachment, right eye | Excludes1 — full neurosensory RD; mutually exclusive with H35.7x |
| H33.22 | Serous retinal detachment, left eye | Excludes1 — mutually exclusive with H35.7x |
| H43.811 | Posterior vitreous detachment, right eye | May coexist — separately reportable |
| H43.812 | Posterior vitreous detachment, left eye | May coexist — separately reportable |
Coding Examples
Example 1 — Acute CSC, Right Eye, New Patient, Observation Plan
Scenario: A 38-year-old male presents with a 3-week history of blurred central vision and micropsia, right eye. OCT reveals dome-shaped subretinal fluid over the macula with a small serous PED at the leak point. FA shows a classic “smokestack” leakage pattern. Provider documents: “Acute central serous chorioretinopathy, right eye — observation for 3 months; likely spontaneous resolution.”
First-listed Dx: H35.711 — Central serous chorioretinopathy, right eye (type + laterality documented — H35.70 is incorrect here) Additional Dx: H35.721 — Serous detachment of RPE, right eye (the small serous PED at the leak point is a separately documentable finding — Excludes2 allows both) CPT: 92004--RT; 92134--RT; 92235--RT Notes: H35.70 would be an undercoding error — both the type (CSC) and laterality (right eye) are documented. The small serous PED is separately codeable alongside the CSC diagnosis.
Example 2 — Chronic CSC, Left Eye, PDT Treatment
Scenario: A 45-year-old male with chronic CSC left eye (duration >6 months) presents for half-dose PDT. ICGA confirms choroidal hyperpermeability. OCT shows persistent subretinal fluid, shallow but diffuse. Provider documents: “Chronic central serous chorioretinopathy, left eye — half-dose (30%) verteporfin PDT performed today.”
First-listed Dx: H35.712 — Central serous chorioretinopathy, left eye CPT: 67221--LT — PDT, single session, left eye Notes: H35.70 is incorrect. The 90-day global period for 67221 applies — all related post-PDT follow-up for 90 days is bundled. A 2026 meta-analysis confirms half-dose PDT is the superior treatment for chronic CSC, achieving ~4x better fluid resolution than observation at 1 month with durable benefit through 12 months.7
Example 3 — Serous RPE Detachment, Right Eye, Wet AMD, Anti-VEGF Injection
Scenario: A 74-year-old patient with known exudative AMD presents for follow-up OCT. OCT reveals a dome-shaped serous PED of the right eye with surrounding subretinal fluid. Active CNV confirmed on OCTA. Provider documents: “Exudative AMD with active CNV and serous PED, right eye — intravitreal anti-VEGF injection today.”
First-listed Dx: H35.3211 — Exudative AMD, right eye, with active choroidal neovascularization (AMD is the underlying condition driving the encounter — sequences first) Additional Dx: H35.721 — Serous detachment of RPE, right eye (separately reportable manifestation — Excludes2 at H35 category level permits dual coding) CPT: 92014--RT; 92134--RT; 92137--RT (OCTA); 67028--RT (intravitreal injection) HCC Impact: H35.3211 → HCC 124 — must be captured on every encounter for risk adjustment Notes: H35.70 is incorrect here — both the type (serous PED) and the underlying AMD etiology are documented. Missing H35.3211 means missing HCC 124 on this claim — a direct RAF score impact.
Example 4 — Hemorrhagic RPE Detachment, Left Eye, AMD, Urgent Anti-VEGF
Scenario: A 79-year-old patient with known wet AMD presents urgently with sudden vision loss in the left eye. OCT reveals a large dense hemorrhagic PED with posterior shadowing, left eye. FA shows blocked fluorescence. OCTA identifies active CNV. Provider documents: “Hemorrhagic PED, left eye — exudative AMD with CNV; urgent intravitreal bevacizumab injection.”
First-listed Dx: H35.3221 — Exudative AMD, left eye, with active CNV (AMD with CNV is the underlying condition) Additional Dx: H35.732 — Hemorrhagic detachment of RPE, left eye (separately reportable; Excludes2 permits dual coding) CPT: 92014--LT; 92134--LT; 92235--LT; 67028--LT HCC Impact: H35.3221 → HCC 124 Notes: H35.70 would be an error — both the type (hemorrhagic PED) and laterality (left eye) are clearly documented. Without H35.3221, this encounter contributes no HCC weight to the patient’s RAF score despite the clinical severity.
Example 5 — Scenario Where H35.70 IS Appropriate
Scenario: An inpatient ophthalmology consult note documents: “Macular evaluation performed. Some separation of retinal layers noted on examination. Recommend outpatient OCT for further characterization.” No eye is specified; no type is specified.
Diagnosis Code: H35.70 — Unspecified separation of retinal layers (appropriate — type and laterality genuinely undocumented in this incomplete consult) CDI Action: Query the consulting ophthalmologist for (1) which eye was examined and (2) the type of retinal layer separation observed — this information will be needed before outpatient follow-up coding can be accurate Notes: This is the legitimate clinical scenario for H35.70 — an incomplete inpatient consult note. The code is appropriate as a placeholder. The goal is to retire it with a specific H35.71x, H35.72x, or H35.73x code once OCT documentation and provider clarification are obtained.
Example 6 — Bilateral CSC, Diabetic Patient — Dual Code Requirement
Scenario: A 42-year-old male with type 2 diabetes and a history of corticosteroid use presents with bilateral subretinal fluid on OCT. Provider documents: “Bilateral CSC — bilateral central serous chorioretinopathy. Type 2 diabetes with background diabetic retinopathy also present.”
First-listed Dx: H35.713 — Central serous chorioretinopathy, bilateral (bilateral CSC — bilateral code required over two unilateral codes) Additional Dx: E11.329 — Type 2 DM with mild nonproliferative diabetic retinopathy, unspecified eye (or more specific diabetic code per documentation — Excludes2 requires separate coding of diabetic retinopathy alongside H35.7x) CPT: 92014; 92134-50 (bilateral OCT) HCC Impact: E11.329 → HCC 122 under CMS-HCC v28 — must be captured Notes: The Excludes2 instruction at the H35 category level is non-negotiable — both H35.713 and the appropriate E11 diabetic retinopathy code must be assigned when both are documented. Omitting the diabetic code loses HCC 122 and inaccurately represents the clinical complexity of this patient.
Coding Pitfalls & Tips
Common Errors
- Using H35.70 when type is documented — if OCT or FA findings describe CSC, serous PED, or hemorrhagic PED anywhere in the clinical note, the appropriate H35.71x, H35.72x, or H35.73x code is required; H35.70 is reserved for true type-indeterminate scenarios
- Omitting the AMD code when serous/hemorrhagic PED is secondary to wet AMD — this is the highest-stakes coding error in the H35.7 family; H35.721-H35.733 paired with H35.32- (exudative AMD) is required; the AMD code carries HCC 124 and must be captured at every eligible encounter9
- Omitting the diabetic retinopathy code — the Excludes2 at H35 category level means diabetic retinal disorders must always be coded separately when documented; failure results in both an ICD-10-CM convention violation and a missed HCC 122 opportunity3
- Coding H35.7x AND H33.2x for the same eye — serous retinal detachment (H33.2x) and separation of retinal layers (H35.7x) are Excludes1 — mutually exclusive; the anatomical distinction must be documented; do not code both simultaneously for the same eye1
- Not upgrading to bilateral code H35.713 when bilateral CSC is documented — the bilateral code takes precedence over two separate unilateral codes per ICD-10-CM convention
- Billing 92137 (OCTA) under 92134 — since January 1, 2025, OCTA has its own Category I CPT code (92137); reporting OCTA under 92134 is incorrect and understates the service rendered8
- Billing 92235 + 92240 separately when combined FA+ICGA was performed — 92242 (new 2025 code) is the correct code for the combined study15
Pro Tips
- H35.70 on a finalized retina claim = documentation gap — if OCT has been performed and documented (which it almost always is in retina practice), the type of retinal layer separation is determinable; H35.70 should not survive the coding review process in a well-managed practice
- OCTA (92137) has transformed CSC and RPE detachment evaluation — it noninvasively images the choriocapillaris, identifies CNV in serous and hemorrhagic PED, and maps flow voids in pachychoroid CSC; ensure this new 2025 CPT code is in your practice’s charge capture workflow8
- CSC in steroid users: When corticosteroid use (systemic or inhaled) is documented as a precipitating factor for CSC, consider whether an external cause code or a steroid-related adverse effect code applies — document the steroid use and CSC relationship explicitly in the note
- Half-dose PDT for CSC carries a 90-day global period — track post-PDT follow-up visit dates carefully; visits within 90 days that address the PDT outcome are bundled; only separately identifiable conditions with modifier -24 are separately billable during the global window
- Bilateral CSC is more common than generally recognized — approximately 20-30% of CSC patients have bilateral involvement; always document the status of both eyes on OCT at each encounter; bilateral coding (H35.713) is appropriate when confirmed and avoids two-unilateral-code convention violations
CDI Query Opportunities
CDI Flags — Two Priority Queries + One HCC Query for Every H35.70 Encounter
- Separation type: What type of retinal layer separation is present — CSC, serous RPE detachment, or hemorrhagic RPE detachment? Query the provider for type documentation — OCT findings almost always provide this information → upgrades H35.70 to H35.71x, H35.72x, or H35.73x
- Eye laterality: Which eye is affected — right, left, or bilateral? Query the provider for laterality documentation → further upgrades to the most specific code in the appropriate family
- Underlying AMD: Is exudative AMD the underlying cause of the serous or hemorrhagic PED? Query the provider to confirm and document the AMD diagnosis explicitly — this unlocks HCC 124 on the claim and cannot be inferred or assumed by the coder alone9
- Diabetic etiology: Is the patient diabetic and is diabetic retinopathy present? Query if diabetes is in the chart but no diabetic retinopathy code accompanies the H35.7x — the Excludes2 instruction requires both codes when both conditions exist3
- CSC duration: Is the CSC acute (<3-4 months) or chronic (>3-4 months)? While ICD-10-CM does not distinguish between acute and chronic CSC in the H35.71x code family, documenting duration matters for treatment decisions (PDT vs. observation) and medical necessity for 67221
- Subretinal fluid status: Is subretinal fluid present beneath the neurosensory retina in addition to the RPE-level separation? If both serous PED and overlying subretinal fluid are documented, both H35.71x (CSC) and H35.72x (serous PED) may be separately reportable — query for confirmation
Related Codes
- Type + laterality upgrades: H35.711, H35.712, H35.713, H35.719, H35.721, H35.722, H35.723, H35.729, H35.731, H35.732, H35.733, H35.739
- AMD — HCC 124 (code separately): H35.3211, H35.3212, H35.3213, H35.3221, H35.3222, H35.3223
- Diabetic retinopathy — HCC 122 (code separately): E11.3511-E11.3593; E10.3511-E10.3593
- Excludes1 — mutually exclusive: H33.21, H33.22, H33.23 (serous RD)
- Associated PVD: H43.811, H43.812, H43.813
- Degenerative myopia: H44.2A1, H44.2A2, H44.2A3
- CPT crosswalk: 67028, 67221, 67225, 67210, 67228, 92134, 92137, 92235, 92240, 92242, 92225, 92226
- AAPC Codify — ICD-10-CM H35.70, H35.72, H35.73 Excludes1 Notes, aapc.com
- Retina Today — A Deep Dive on Central Serous Chorioretinopathy, retinatoday.com (2018)
- CMS — ICD-10-CM Official Guidelines for Coding and Reporting FY2026, cms.gov
- CMS — ICD-10-CM/PCS MS-DRG v37.2 Definitions Manual, cms.gov
- FindACode — ICD-10-CM H35.70, findacode.com
- ICD List — ICD-10-CM H35.7 Separation of Retinal Layers, icdlist.com
- PubMed 41833620 — Photodynamic therapy and anti-VEGF versus observation in acute CSC: Meta-analysis, Surv Ophthalmol (2026)
- Eyes on Eyecare / Glance — New OCTA CPT Code 92137 Goes Into Effect January 2025, glance.eyesoneyecare.com
- BCA — HCC Updates: Capturing Risk Accurately in 2026, bcarev.com (2026)
- CMS — 2026 Model Software/ICD-10 Mappings, cms.gov
- Unbound Medicine — H35.71 CSC; H35.72 Serous RPE Detachment; H35.73 Hemorrhagic RPE Detachment, unboundmedicine.com
- ASRS — Retina Coding Update 2025, asrs.org
- PMC 6897067 — Central Serous Chorioretinopathy: Pathogenesis and Management, pmc.ncbi.nlm.nih.gov (2019)
- PMC 3939727 — Photodynamic Therapy and Central Serous Chorioretinopathy, pmc.ncbi.nlm.nih.gov
- Optos — 2026 Retinal Imaging CPT Codes and Rates USA, optos.com (updated 01/2026)
- PMC 9954782 — Giant RPE Tear Resulting in Neurosensory Retinal Detachment, pmc.ncbi.nlm.nih.gov (2022)
- ECGWaves — ICD-10-CM H35.70 Unspecified Separation of Retinal Layers, ecgwaves.com
- Retinal Physician — CPT Coding for OCT Angiography (92134 → 92137 transition background), retinalphysician.com